Search Within

Hongmei Xing

Formats
  1. Journal Article (8)
  2. Meeting Abstract (4)
Groups
  1. Department of Medicine (12)
  2. Division of Subspecialty Medicine (12)
  3. Endocrinology (12)
  4. GSK Faculty (12)
  5. Molecular Pharmacology and Chemistry Program Faculty (12)
  6. Sloan Kettering Institute Faculty (12)

More Groups

People
  1. Richard Kolesnick (12)
  2. Zvi Fuks (4)
  3. Carlos Cordon-Cardo (3)
  4. Luis Campodonico (3)
  5. Jose Lozano (2)
  6. William Tong (2)

More People

Years
  1. 2006 (1)
  2. 2005 (2)
  3. 2004 (2)
  4. 2003 (3)
  5. 2002 (1)
  6. 2000 (1)

More Years

Publications
  1. Cancer Research (3)
  2. Journal of Biological Chemistry (2)
  3. Nature Medicine (2)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (2)
  5. Innate Immunity (1)
  6. Journal of Clinical Investigation (1)

More Publications

Publishers
  1. American Association for Cancer Research (5)
  2. American Society for Biochemistry and Molecular Biology (2)
  3. Nature Publishing Group (2)
  4. American Society for Clinical Investigation (1)
  5. Sage (1)
  6. Sage Publications (1)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • KSR1 translocation into plasma membrane rafts is required for KSR1 kinase activation
    Meeting Abstract

    Yin, X.; Zafrullah, M.; Xing, H. R.; Kolesnick, R.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Kinase suppressor of Ras1 phosphorothioate antisense oligonucleotide treatment inhibits oncogenic K-Ras-mediated tumorigenesis and metastasis in an orthotopic model of human pancreatic cancer
    Meeting Abstract

    Xing, R. H.; Fuks, Z.; Kolesnick, R.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • ATM regulates target switching to escalating doses of radiation in the intestines
    Journal Article

    Chang, H. J.; Maj, J. G.; Paris, F.; Xing, H. R.; Zhang, J.; Truman, J. P.; Cordon-Cardo, C.; Haimovitz-Friedman, A.; Kolesnick, R.; Fuks, Z.
    Nature Medicine (2005)

    Fulltext@MSK | Save
  • The kinase activity of kinase suppressor of Ras1 (KSR1) is independent of bound MEK
    Journal Article

    Xing, H. R.; Campodonico, L.; Kolesnick, R.
    Journal of Biological Chemistry (2004)

    Fulltext@MSK | Save
  • Inflammatory bowel disease reveals the kinase activity of KSR1
    Journal Article

    Kolesnick, R.; Xing, H. R.
    Journal of Clinical Investigation (2004)

    Fulltext@MSK | Save
  • Kinase suppressor of Ras inactivation abrogates oncogenic Ras-mediated tumorigenesis in human pancreatic cancer
    Meeting Abstract

    Xing, R. H.; Cordon-Cardo, C.; Deng, X.; Tong, W.; Campodonico, L.; Fuks, Z.; Kolesnick, R. N.
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Pharmacologic inactivation of kinase suppressor of ras-1 abrogates Ras-mediated pancreatic cancer
    Journal Article

    Xing, H. R.; Cordon-Cardo, C.; Deng, X.; Tong, W.; Campodonico, L.; Fuks, Z.; Kolesnick, R.
    Nature Medicine (2003)

    Fulltext@MSK | Save
  • Deficiency of kinase suppressor of Ras1 prevents oncogenic Ras signaling in mice
    Journal Article

    Lozano, J.; Xing, R.; Cai, Z.; Jensen, H. L.; Trempus, C.; Mark, W.; Cannon, R.; Kolesnick, R.
    Cancer Research (2003)

    Fulltext@MSK | Save
  • Kinase suppressor of Ras (KSR) is an essential component of epidermal growth factor receptor (EGFR)/Ras-mediated tumorigenesis
    Meeting Abstract

    Xing, R. H.; Kolesnick, R. N.
    Proceedings of the American Association for Cancer Research Annual Meeting (2002)

    Fulltext@MSK | Save
  • Epidermal growth factor treatment enhances the kinase activity of kinase suppressor of Ras
    Journal Article

    Xing, H. R.; Lozano, J.; Kolesnick, R.
    Journal of Biological Chemistry (2000)

    Fulltext@MSK | Save